Pharma Equity Group A/S (PEG.CO)

DKK 0.18

(-2.17%)

Long Term Debt Summary of Pharma Equity Group A/S

  • Pharma Equity Group A/S's latest annual long term debt in 2023 was 8.07 Million DKK , up 2736171.19% from previous year.
  • Pharma Equity Group A/S's latest quarterly long term debt in 2024 Q2 was 18.51 Million DKK , up 16.85% from previous quarter.
  • Pharma Equity Group A/S reported annual long term debt of 295.00 DKK in 2022, down -100.0% from previous year.
  • Pharma Equity Group A/S reported annual long term debt of 6.58 Million DKK in 2021, down 0.0% from previous year.
  • Pharma Equity Group A/S reported quarterly long term debt of 15.84 Million DKK for 2024 Q1, up 102.11% from previous quarter.
  • Pharma Equity Group A/S reported quarterly long term debt of 124 Thousand DKK for 2023 Q2, down -44.14% from previous quarter.

Annual Long Term Debt Chart of Pharma Equity Group A/S (2023 - 2008)

Historical Annual Long Term Debt of Pharma Equity Group A/S (2023 - 2008)

Year Long Term Debt Long Term Debt Growth
2023 8.07 Million DKK 2736171.19%
2022 295.00 DKK -100.0%
2021 6.58 Million DKK 0.0%
2020 - DKK 0.0%
2019 - DKK 0.0%
2018 - DKK 0.0%
2017 - DKK 0.0%
2016 - DKK -100.0%
2015 16.91 Million DKK 0.0%
2014 - DKK -100.0%
2013 150.27 Million DKK -35.67%
2012 233.6 Million DKK 24.48%
2011 187.66 Million DKK -22.19%
2010 241.19 Million DKK 2298.49%
2009 10.05 Million DKK 0.0%
2008 - DKK 0.0%

Peer Long Term Debt Comparison of Pharma Equity Group A/S

Name Long Term Debt Long Term Debt Difference
ALK-Abelló A/S 439 Million DKK 98.161%
Bavarian Nordic A/S 15.13 Million DKK 46.667%
Genmab A/S 680 Million DKK 98.813%
Gubra A/S 60.68 Million DKK 86.699%
Novo Nordisk A/S 20.52 Billion DKK 99.961%
Orphazyme A/S - DKK -Infinity%
Zealand Pharma A/S 102.57 Million DKK 92.131%